arrow_back Back Filing freshness 10-Q Q1 FY2026 SEC EDGAR

ASP Isotopes Inc.

ASPI
$4.44 ▲ +0.35 (+8.56%) at close
Materials ·Miscellaneous Chemical Products ·USMiscellaneous Chemical Products
19 Visible periods
29 Metrics
Peer-ranked Benchmarks
Price Chart
19
Health
Poor
Moderately Bearish
auto_awesome

Analytical Summary

ASP Isotopes Inc. faces fundamental challenges with weakness in Return on Common Equity (%). Investors should exercise caution and monitor for improvement in key metrics.

Market Cap $537.2M
Dividend Yield
Revenue Growth 279.4%
Op. Margin None
ROIC -7.2%
FCF / Share $-0.20
Trailing P/E
Price / Book 1.9x
FCF Yield
Debt / Equity 0.20
info Valuation on last close. End-of-day price, Aug 7, 2026.

19-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$4.18M
↑ +279.4%
Net Income Profit after all expenses
$-7.12M
↑ +15.8%
Operating Margin Operating profit as % of sales
-150.2%
↑ +50.9% 0th
FCF / Share Free cash flow per share
$-0.20
↓ -150.4%
Long-Term Debt Long-term obligations
$58.33M
↑ +306.3%
trending_up

Bullish Indicators

  • Debt to EquityDebt to Equity is in the top quartile (lower is better)
warning

Bearish Risks

  • Operating Margin (%)Operating Margin (%) is in the bottom quartile
  • Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Profitability
1
Returns
11
Financial Health
43
Cash Quality
32

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 5 years · 19 quarters